Upload

Loading icon Loading...

This video is unavailable.

2011 Summit: Translational Medicine: Key to Progress or Bridge to Nowhere?, Andrew S. Grove, PhD

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like Genetics Policy Institute's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike Genetics Policy Institute's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add Genetics Policy Institute's video to your playlist.

Uploaded on Dec 13, 2011

Andy Grove, PhD and Former CEO of Intel Corporation, dared to suggest that translational medicine will be a "bridge to nowhere" if the way we handle the development of new drugs does not undergo a serious transformation. He proposed a radical rethinking of our whole regulatory and IP system, encouraging all members of the stem cell community to stimulate action and push for change. Grove asked attendees to consider how stem cell science will live in the current system and to pioneer innovative ways to get therapies to the clinic faster.

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

The interactive transcript could not be loaded.

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading icon Loading...

Loading...
Working...
to add this to Watch Later

Add to